Many consider Nanosonics as ‘the next CSL’ given its market opportunity and growth capabilities. While Nanosonics hasn’t released any market sensitive updates since its AGM back in November, there are still many reasons why Nanosonics is set for another record 2020.
The company’s business activity in Japan remains a key growth market – a preliminary study in Japan found that over 90% of ultrasound probes were contaminated and of the contaminated probes, 50% were found to harbour deadly pathogenic bacteria. It will be interesting to see whether or not Nanosonics have started sales in this region. China also represents a significant market opportunity. The company is only undertaking a preliminary assessment of the market with visits to large hospitals, the Chinese Centre for Disease control and regulatory authorities.
NAN in Japan
Add NAN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.75 |
Change
-0.010(0.36%) |
Mkt cap ! $833.1M | |||
| Open | High | Low | Value | Volume |
| $2.73 | $2.76 | $2.71 | $1.479M | 541.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 2044 | $2.74 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.76 | 10000 | 1 |
View Market Depth
| Last trade - 16.10pm 26/04/2024 (20 minute delay) ? |
|
|||||
|
Last
$2.76 |
Change
-0.010 ( 0.41 %) |
||||
| Open | High | Low | Volume | ||
| $2.72 | $2.76 | $2.71 | 172952 | ||
| Last updated 15.59pm 26/04/2024 ? | |||||
| NAN (ASX) Chart |